58 results
Page 3 of 3
424B5
2nqdxk
3 Mar 14
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
0mqg9m330ia32
3 Mar 14
Current report (foreign)
12:00am
424B3
3h2h221ou wunne
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-10.1
dmm4k4p
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
424B5
00gnqqq5zugg
6 Feb 13
Prospectus supplement for primary offering
12:00am
6-K
EX-99
dym3v 49pc9wjgl
16 Oct 12
BioLineRx Announces Successful Completion of Pre-Clinical
12:00am
424B3
8u5b7027dvhgsmj07
15 Oct 12
Prospectus supplement
12:00am
F-1
swzp 7oh9mdvvegsoun
2 Oct 12
Registration statement (foreign)
12:00am
424B3
dfor 87t2
28 Mar 12
Prospectus supplement
12:00am
20-F
rqet0
22 Mar 12
Annual report (foreign)
12:00am
6-K
EX-99.2
q08gmnaztqz88
16 Feb 12
Current Report, Foreign Issuer
12:00am
6-K
EX-1
z8pnpc ccmdrn70
21 Nov 11
BioLineRx Announces Receipt of Approval in India
12:00am
20FR12B/A
xuk3m0
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
awn6dcg2x12w k1iyl
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.17
0efgmgnregzcliq
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
F-1
EX-10.17
mrjo5sdms id4zea
24 Sep 10
Registration statement (foreign)
12:00am
F-1
ihr 0u22zse
24 Sep 10
Registration statement (foreign)
12:00am